G1 Therapeutics, Inc. Annual Operating Income (Loss) in USD from 2015 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
G1 Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2015 to 2023.
  • G1 Therapeutics, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$3.54M, a 131% decline year-over-year.
  • G1 Therapeutics, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$37.9M, a 43.2% increase year-over-year.
  • G1 Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$39.5M, a 71% increase from 2022.
  • G1 Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$136M, a 4.41% increase from 2021.
  • G1 Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$142M, a 47.7% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$39.5M +$96.7M +71% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 -$136M +$6.28M +4.41% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 -$142M -$46M -47.7% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 -$96.5M +$32.6M +25.2% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 -$129M -$39.8M -44.5% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-23
2018 -$89.3M -$28.3M -46.4% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-24
2017 -$61M -$30.6M -101% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-26
2016 -$30.4M -$15M -97% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 -$15.4M Jan 1, 2015 Dec 31, 2015 10-K 2018-02-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.